Fiera Capital (Canada)’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,354,469
| Closed | -$39.1M | – | 455 |
|
|
2024
Q3 | $39.1M | Sell |
1,354,469
-46,721
| -3% | -$1.35M | 0.12% | 117 |
|
|
2024
Q2 | $53.7M | Buy |
1,401,190
+452,753
| +48% | +$17.4M | 0.17% | 88 |
|
|
2024
Q1 | $55.7M | Buy |
948,437
+29,347
| +3% | +$1.73M | 0.16% | 91 |
|
|
2023
Q4 | $55M | Sell |
919,090
-600
| -0.1% | -$35.9K | 0.17% | 89 |
|
|
2023
Q3 | $35M | Buy |
919,690
+391,770
| +74% | +$14.9M | 0.11% | 111 |
|
|
2023
Q2 | $48.1M | Sell |
527,920
-12,462
| -2% | -$1.14M | 0.14% | 87 |
|
|
2023
Q1 | $35.6M | Buy |
+540,382
| New | +$35.6M | 0.11% | 109 |
|